<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735564</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 2015-064</org_study_id>
    <nct_id>NCT02735564</nct_id>
  </id_info>
  <brief_title>Change in Reward System Activation and Gut Microbiota Following RYGB and Sleeve Gastrectomy for Weight Loss vs. Control-Heads Up Ancillary</brief_title>
  <official_title>Change in Reward System Activation and Gut Microbiota Following Roux-en-y and Sleeve Gastrectomy for Weight Loss as Compared to a Control- Heads Up Ancillary</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bariatric surgery is considered an effective long-term intervention for the treatment of&#xD;
      obesity and associated complications. While bariatric surgery has been shown to result in a&#xD;
      large sustained weight loss, the degree of weight loss and maintenance thereafter varies&#xD;
      greatly. The Heads Up Surgical Demonstration Project (Heads Up) is a 5 year project examining&#xD;
      weight loss after an intensive medical intervention (IMI) and the 2 most widely used&#xD;
      bariatric surgeries (roux-en-y gastric bypass or RYGB and sleeve gastrectomy or SG). Baseline&#xD;
      data are collected prior to surgery and follow-up data are collected at 6 months and annually&#xD;
      thereafter. A recent meta-analysis revealed that RYGB resulted in greater weight loss and is&#xD;
      more effective in resolving obesity related comorbidities than SG, although SG has been shown&#xD;
      to result in a reduction of perioperative complications and reoperations1. Full elucidation&#xD;
      of the mechanisms leading to variation in success for weight loss interventions is crucial to&#xD;
      understanding the most effective and reliable treatments for obesity and associated&#xD;
      comorbidities.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neural reward sensitivity</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>Investigate change in reward activation patterns in the brain in response to food cues using fMRI.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>gut microbiota</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>Determine if gut microbiota, as analyzed via stool sample collection, changes from baseline (prior to surgery) to 6 months follow-up (post-surgery) among the groups.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>RYGB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bariatric Surgery:Roux-en-y</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bariatric Surgery: Sleeve Gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>BMI matched control</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bariatric Surgery</intervention_name>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>RYGB</arm_group_label>
    <arm_group_label>SG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Surgical Groups (RYGB and SG) Inclusion criteria for the two surgery groups (n=16)&#xD;
&#xD;
          -  Individuals who qualify for Heads Up and would like to participate in this ancillary&#xD;
             study&#xD;
&#xD;
          -  Be willing to participate in additional procedures including: 4 brains scans (2 before&#xD;
             surgery and 2 after surgery), 2 meal challenges (1 before surgery and 1 after&#xD;
             surgery), and 2 microbiota collections (1 before surgery and 1 after surgery).&#xD;
&#xD;
          -  Be willing to archive microbiota samples&#xD;
&#xD;
        Control Group:&#xD;
&#xD;
        Inclusion Criteria for the BMI matched control group (n=9):&#xD;
&#xD;
          -  Males and females age 21-70 years&#xD;
&#xD;
          -  Body Mass Index ≥40 kg/m2 without type 2 diabetes or ≥35 kg/m2 and ≤ 60kg/m² with type&#xD;
             2 diabetes&#xD;
&#xD;
          -  Agree to receive frequent contacts from investigators and communicate with program&#xD;
             staff for up to 6 months&#xD;
&#xD;
          -  Able to give written informed consent&#xD;
&#xD;
          -  Able to comply with study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion Criteria for the two surgery groups (n=16):&#xD;
&#xD;
               -  Unable or unwilling to give informed consent&#xD;
&#xD;
               -  Pregnant or planning on becoming pregnant during the 6 months you participate in&#xD;
                  the study&#xD;
&#xD;
               -  History or presence of unremoveable metal objects (medical or dental) or&#xD;
                  electronic devices or other contraindication to MRI scanning.&#xD;
&#xD;
               -  Unwillingness to complete an MRI due to confined space or other related phobias&#xD;
&#xD;
        Exclusion Criteria for the BMI matched control group (n=9):&#xD;
&#xD;
          -  Unable or unwilling to give informed consent&#xD;
&#xD;
          -  Hospitalization for psychiatric illness or substance use/abuse within the past year&#xD;
&#xD;
          -  Diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, or&#xD;
             personality disorder as determined by the medical staff&#xD;
&#xD;
          -  Travel plans that do not permit participation&#xD;
&#xD;
          -  Pregnant or planning on becoming pregnant during the 6 months you participate in the&#xD;
             study&#xD;
&#xD;
          -  History of prior bariatric surgery, extensive bowel resection, or hiatal hernia repair&#xD;
             (unless approved by the medical staff)&#xD;
&#xD;
          -  History of eating disorder such as anorexia nervosa, bulimia, or binge eating (unless&#xD;
             approved by program staff)&#xD;
&#xD;
          -  Current major depressive episode or history of suicidal behaviors&#xD;
&#xD;
          -  Severe congestive heart failure (NYHA class III, IV)&#xD;
&#xD;
          -  Second degree or greater heart block&#xD;
&#xD;
          -  Other medical, psychiatric, or behavioral limitations that in the judgement of the&#xD;
             investigator may interfere with program participation or the ability to follow the&#xD;
             intervention protocol&#xD;
&#xD;
          -  History or presence of unremoveable metal objects (medical or dental) or electronic&#xD;
             devices or other contraindication to MRI scanning.&#xD;
&#xD;
          -  Unwillingness to complete an MRI due to confined space or other related phobias&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keely Hawkins, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808-4124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>April 6, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <last_update_submitted>January 3, 2020</last_update_submitted>
  <last_update_submitted_qc>January 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Corby K. Martin</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Weight Loss</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>gut microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

